ABC of Dermatology Fourth Edition
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Obstetrics and Gynecology Pretest® Self-Assessment and Review 10412 Wylen Fm.£.Qxd 6/18/03 10:55 AM Page Ii
10412_Wylen_fm.£.qxd 6/18/03 10:55 AM Page i PRE ® TEST Obstetrics and Gynecology PreTest® Self-Assessment and Review 10412_Wylen_fm.£.qxd 6/18/03 10:55 AM Page ii Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the prod- uct information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This recommendation is of particular importance in connection with new or infrequently used drugs. 10412_Wylen_fm.£.qxd 6/18/03 10:55 AM Page iii PRE ® TEST Obstetrics and Gynecology PreTest® Self-Assessment and Review Tenth Edition Michele Wylen, M.D. -
3628-3641-Pruritus in Selected Dermatoses
Eur opean Rev iew for Med ical and Pharmacol ogical Sci ences 2016; 20: 3628-3641 Pruritus in selected dermatoses K. OLEK-HRAB 1, M. HRAB 2, J. SZYFTER-HARRIS 1, Z. ADAMSKI 1 1Department of Dermatology, University of Medical Sciences, Poznan, Poland 2Department of Urology, University of Medical Sciences, Poznan, Poland Abstract. – Pruritus is a natural defence mech - logical self-defence mechanism similar to other anism of the body and creates the scratch reflex skin sensations, such as touch, pain, vibration, as a defensive reaction to potentially dangerous cold or heat, enabling the protection of the skin environmental factors. Together with pain, pruritus from external factors. Pruritus is a frequent is a type of superficial sensory experience. Pruri - symptom associated with dermatoses and various tus is a symptom often experienced both in 1 healthy subjects and in those who have symptoms systemic diseases . Acute pruritus often develops of a disease. In dermatology, pruritus is a frequent simultaneously with urticarial symptoms or as an symptom associated with a number of dermatoses acute undesirable reaction to drugs. The treat - and is sometimes an auxiliary factor in the diag - ment of this form of pruritus is much easier. nostic process. Apart from histamine, the most The chronic pruritus that often develops in pa - popular pruritus mediators include tryptase, en - tients with cholestasis, kidney diseases or skin dothelins, substance P, bradykinin, prostaglandins diseases (e.g. atopic dermatitis) is often more dif - and acetylcholine. The group of atopic diseases is 2,3 characterized by the presence of very persistent ficult to treat . Persistent rubbing, scratching or pruritus. -
Skin Eruptions Specific to Pregnancy: an Overview
DOI: 10.1111/tog.12051 Review The Obstetrician & Gynaecologist http://onlinetog.org Skin eruptions specific to pregnancy: an overview a, b Ajaya Maharajan MBBS DGO MRCOG, * Christina Aye BMBCh MA Hons MRCOG, c d Ravi Ratnavel DM(Oxon) FRCP(UK), Ekaterina Burova FRCP CMSc (equ. PhD) aConsultant in Obstetrics and Gynaecology, Luton and Dunstable University Hospital, Lewsey Road, Luton, Bedfordshire LU4 0DZ, UK bST5 in Obstetrics and Gynaecology, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK cConsultant Dermatologist, Buckinghamshire Health Care, Mandeville Road, Aylesbury, Buckinghamshire HP21 8AL, UK dConsultant Dermatologist, Skin Cancer Lead for Bedford Hospital, Bedford Hospital NHS Trust, South Wing, Kempston Road, Bedford MK42 9DJ, UK *Correspondence: Ajaya Maharajan. Email: [email protected] Accepted on 31 January 2013 Key content Learning objectives Pregnancy results in various physiological skin changes. To understand the physiological skin changes in pregnancy. As a consequence, some common dermatoses can present more To identify the skin conditions that require appropriate referral. frequently in pregnant women. In addition, there are a number To be able to take a history, to diagnose the skin eruptions unique to of skin eruptions unique to pregnancy. pregnancy, undertake appropriate investigations and first-line The aetiology of physiological skin changes in pregnancy is management, and understand the criteria for referral to a uncertain but is thought to be due to hormonal and physical dermatologist. changes of pregnancy. Keywords: atopic eruption of pregnancy / intrahepatic cholestasis The four dermatoses of pregnancy are: atopic eruption of pregnancy / pemphigoid gestastionis / polymorphic eruption of of pregnancy, pemphigoid gestationis, polymorphic pregnancy / skin eruptions eruption of pregnancy and intrahepatic cholestasis of pregnancy. -
Pruritus: Scratching the Surface
Pruritus: Scratching the surface Iris Ale, MD Director Allergy Unit, University Hospital Professor of Dermatology Republic University, Uruguay Member of the ICDRG ITCH • defined as an “unpleasant sensation of the skin leading to the desire to scratch” -- Samuel Hafenreffer (1660) • The definition offered by the German physician Samuel Hafenreffer in 1660 has yet to be improved upon. • However, it turns out that itch is, indeed, inseparable from the desire to scratch. Savin JA. How should we define itching? J Am Acad Dermatol. 1998;39(2 Pt 1):268-9. Pruritus • “Scratching is one of nature’s sweetest gratifications, and the one nearest to hand….” -- Michel de Montaigne (1553) “…..But repentance follows too annoyingly close at its heels.” The Essays of Montaigne Itch has been ranked, by scientific and artistic observers alike, among the most distressing physical sensations one can experience: In Dante’s Inferno, falsifiers were punished by “the burning rage / of fierce itching that nothing could relieve” Pruritus and body defence • Pruritus fulfils an essential part of the innate defence mechanism of the body. • Next to pain, itch may serve as an alarm system to remove possibly damaging or harming substances from the skin. • Itch, and the accompanying scratch reflex, evolved in order to protect us from such dangers as malaria, yellow fever, and dengue, transmitted by mosquitoes, typhus-bearing lice, plague-bearing fleas • However, chronic itch lost this function. Chronic Pruritus • Chronic pruritus is a common and distressing symptom, that is associated with a variety of skin conditions and systemic diseases • It usually has a dramatic impact on the quality of life of the affected individuals Chronic Pruritus • Despite being the major symptom associated with skin disease, our understanding of the pathogenesis of most types of itch is limited, and current therapies are often inadequate. -
Copyrighted Material
Part 1 General Dermatology GENERAL DERMATOLOGY COPYRIGHTED MATERIAL Handbook of Dermatology: A Practical Manual, Second Edition. Margaret W. Mann and Daniel L. Popkin. © 2020 John Wiley & Sons Ltd. Published 2020 by John Wiley & Sons Ltd. 0004285348.INDD 1 7/31/2019 6:12:02 PM 0004285348.INDD 2 7/31/2019 6:12:02 PM COMMON WORK-UPS, SIGNS, AND MANAGEMENT Dermatologic Differential Algorithm Courtesy of Dr. Neel Patel 1. Is it a rash or growth? AND MANAGEMENT 2. If it is a rash, is it mainly epidermal, dermal, subcutaneous, or a combination? 3. If the rash is epidermal or a combination, try to define the SIGNS, COMMON WORK-UPS, characteristics of the rash. Is it mainly papulosquamous? Papulopustular? Blistering? After defining the characteristics, then think about causes of that type of rash: CITES MVA PITA: Congenital, Infections, Tumor, Endocrinologic, Solar related, Metabolic, Vascular, Allergic, Psychiatric, Latrogenic, Trauma, Autoimmune. When generating the differential, take the history and location of the rash into account. 4. If the rash is dermal or subcutaneous, then think of cells and substances that infiltrate and associated diseases (histiocytes, lymphocytes, mast cells, neutrophils, metastatic tumors, mucin, amyloid, immunoglobulin, etc.). 5. If the lesion is a growth, is it benign or malignant in appearance? Think of cells in the skin and their associated diseases (keratinocytes, fibroblasts, neurons, adipocytes, melanocytes, histiocytes, pericytes, endothelial cells, smooth muscle cells, follicular cells, sebocytes, eccrine -
The Frequency of Superficial Mycoses According to Agents Isolated During a Ten-Year Period (1999-2008) in Zagreb Area, Croatia
Acta Dermatovenerol Croat 2010;18(2):92-98 CLINICAL ARTICLE The Frequency of Superficial Mycoses According to Agents Isolated During a Ten-Year Period (1999-2008) in Zagreb Area, Croatia Paola Miklić, Mihael Skerlev, Dragomir Budimčić, Jasna Lipozenčić University Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine, Zagreb, Croatia Corresponding author: SUMMARY Fungal infections involving the skin, hair and nails represent Paola Miklić, MD one of the most common mucocutaneous infections. Significant changes in the epidemiology, etiology and clinical pattern of mycotic University Department of Dermatology infections have been observed during the last years. The aim of this and Venereology retrospective study was to determine the incidence and the etiologic Zagreb University Hospital Center factors of superficial fungal infections in Zagreb area, Croatia, over a and School of Medicine 10-year period (1999-2008). A total of 75828 samples obtained from 67 983 patients were analyzed. Dermatomycosis was verified by culture in Šalata 4 17410 (23%) samples obtained from 16086 patients. Female patients HR-10000 Zagreb were more commonly affected than male (59% vs. 41%). Dermatophytes Croatia were responsible for 63% of all superficial fungal infections, followed by yeasts (36%) and molds (1%). Trichophyton (T.) mentagrophytes [email protected] (both var. interdigitalis and var. granulosa) was the most frequent dermatophyte isolated in 58% of all samples, followed by Microsporum Received: November 10, 2009 (M). canis (29%) and T. rubrum (10%). The most common clinical forms of dermatomycosis were onychomycosis (41%), tinea corporis (17%) Accepted: April 20, 2010 and tinea pedis (12%). Candida spp. was mainly isolated from fingernail debris. -
Therapies for Common Cutaneous Fungal Infections
MedicineToday 2014; 15(6): 35-47 PEER REVIEWED FEATURE 2 CPD POINTS Therapies for common cutaneous fungal infections KENG-EE THAI MB BS(Hons), BMedSci(Hons), FACD Key points A practical approach to the diagnosis and treatment of common fungal • Fungal infection should infections of the skin and hair is provided. Topical antifungal therapies always be in the differential are effective and usually used as first-line therapy, with oral antifungals diagnosis of any scaly rash. being saved for recalcitrant infections. Treatment should be for several • Topical antifungal agents are typically adequate treatment weeks at least. for simple tinea. • Oral antifungal therapy may inea and yeast infections are among the dermatophytoses (tinea) and yeast infections be required for extensive most common diagnoses found in general and their differential diagnoses and treatments disease, fungal folliculitis and practice and dermatology. Although are then discussed (Table). tinea involving the face, hair- antifungal therapies are effective in these bearing areas, palms and T infections, an accurate diagnosis is required to ANTIFUNGAL THERAPIES soles. avoid misuse of these or other topical agents. Topical antifungal preparations are the most • Tinea should be suspected if Furthermore, subsequent active prevention is commonly prescribed agents for dermatomy- there is unilateral hand just as important as the initial treatment of the coses, with systemic agents being used for dermatitis and rash on both fungal infection. complex, widespread tinea or when topical agents feet – ‘one hand and two feet’ This article provides a practical approach fail for tinea or yeast infections. The pharmacol- involvement. to antifungal therapy for common fungal infec- ogy of the systemic agents is discussed first here. -
Tinea Incognito
TINEA INCOGNITO http://www.aocd.org Tinea incognito is a localized skin infection caused by fungus, just like tinea corporis (ringworm) and tinea capitis (scalp ringworm). It is a skin infectious process that looks very different from other fungal infections, both the shape and the degree of involvement. Topical corticosteroid use is the culprit for the difference. Fungal infection, most often caused by Trichophyton rubrum, presents initially as a flat, scaly rash that gradually becomes a circular lesion with a raised border and the border is scaly as it advances. While the lesion enlarges, the center becomes brown or less pigmented. These skin findings comprise of the ringworm we typically see on the body. Lesions can be large or small. At this stage of the disease, if a topical corticosteroid is applied to the lesion, the local inflammation from the fungal infection will be decreased, so to alter the clinical presentation of the typical infection. And this secondary appearance is called tinea incognito. The most common site for this clinical transformation is the face and the back of the hand. The hand is a popular site for a lot of skin diseases, which is why tinea incognito is hard to diagnose and be differentiated from the others. Altered clinical picture of tinea incognito could resemble eczema, psoriasis and other diseases. What makes the clarification important is the difference in treatment approach. Corticosteroid makes tinea worse but helps the other ones. The new appearance of tinea incognito is quite different from other fungal infections. Instead of a localized lesion, it becomes much more extensive and loses its original circular shape, which is one of the most important clinical clues to diagnose fungal infection. -
Tacrolimus-Induced Tinea Incognito
Tacrolimus-Induced Tinea Incognito Narendra Siddaiah, MD; Capt Quenby Erickson, USAF, MC; Gea Miller, MD; Dirk M. Elston, MD Tacrolimus and pimecrolimus represent a new class of topical nonsteroidal medications cur- rently used in the treatment of a variety of inflam- matory skin lesions. We report the case of a patient in whom topical tacrolimus therapy resulted in widespread lesions of tinea incognito. This case shows that partial treatment of derma- tophytosis with griseofulvin may obscure the diagnosis. It also suggests that topical tacro- limus appears capable of inducing widespread dermatophytosis. The clinical appearance in this case was similar to tinea incognito induced by a topical corticosteroid. Cutis. 2004;73:237-238. he term tinea incognito is generally used to describe a dermatophytic infection whose T appearance is modified by the use of cortico- steroids.1 Steroids suppress local immunity, thus pro- moting fungal growth. Lesions often lack the degree of inflammation associated with tinea, and diagnosis is often delayed. Tacrolimus is 1 of 2 topical macrolide calcineurin inhibitors with potent immunomodula- Figure 1. Annular erythematous and scaly patches on tory activity approved in the treatment of atopic the face. dermatitis. We describe the case of a patient with wide- spread tinea incognito secondary to topical tacrolimus. One year before presentation, the child and his Case Report 4-year-old brother were treated with a 6-week course A 9-year-old black male child presented to the der- of griseofulvin 12.5 mg/kg per day for tinea capitis, matology clinic with large erythematous and scaly and his mother was treated with topical antifungal patches on his face, neck, and trunk (Figures 1 and agents for tinea corporis. -
Copyrighted Material
1 Index Note: Page numbers in italics refer to figures, those in bold refer to tables and boxes. References are to pages within chapters, thus 58.10 is page 10 of Chapter 58. A definition 87.2 congenital ichthyoses 65.38–9 differential diagnosis 90.62 A fibres 85.1, 85.2 dermatomyositis association 88.21 discoid lupus erythematosus occupational 90.56–9 α-adrenoceptor agonists 106.8 differential diagnosis 87.5 treatment 89.41 chemical origin 130.10–12 abacavir disease course 87.5 hand eczema treatment 39.18 clinical features 90.58 drug eruptions 31.18 drug-induced 87.4 hidradenitis suppurativa management definition 90.56 HLA allele association 12.5 endocrine disorder skin signs 149.10, 92.10 differential diagnosis 90.57 hypersensitivity 119.6 149.11 keratitis–ichthyosis–deafness syndrome epidemiology 90.58 pharmacological hypersensitivity 31.10– epidemiology 87.3 treatment 65.32 investigations 90.58–9 11 familial 87.4 keratoacanthoma treatment 142.36 management 90.59 ABCA12 gene mutations 65.7 familial partial lipodystrophy neutral lipid storage disease with papular elastorrhexis differential ABCC6 gene mutations 72.27, 72.30 association 74.2 ichthyosis treatment 65.33 diagnosis 96.30 ABCC11 gene mutations 94.16 generalized 87.4 pityriasis rubra pilaris treatment 36.5, penile 111.19 abdominal wall, lymphoedema 105.20–1 genital 111.27 36.6 photodynamic therapy 22.7 ABHD5 gene mutations 65.32 HIV infection 31.12 psoriasis pomade 90.17 abrasions, sports injuries 123.16 investigations 87.5 generalized pustular 35.37 prepubertal 90.59–64 Abrikossoff -
Pretest Obstetrics and Gynecology
Obstetrics and Gynecology PreTestTM Self-Assessment and Review Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the prod- uct information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This recommendation is of particular importance in connection with new or infrequently used drugs. Obstetrics and Gynecology PreTestTM Self-Assessment and Review Twelfth Edition Karen M. Schneider, MD Associate Professor Department of Obstetrics, Gynecology, and Reproductive Sciences University of Texas Houston Medical School Houston, Texas Stephen K. Patrick, MD Residency Program Director Obstetrics and Gynecology The Methodist Health System Dallas Dallas, Texas New York Chicago San Francisco Lisbon London Madrid Mexico City Milan New Delhi San Juan Seoul Singapore Sydney Toronto Copyright © 2009 by The McGraw-Hill Companies, Inc. -
Incidence and Biodiversity of Yeasts, Dermatophytes and Non
Journal de Mycologie Médicale (2017) 27, 166—179 Available online at ScienceDirect www.sciencedirect.com ORIGINAL ARTICLE/ARTICLE ORIGINAL Incidence and biodiversity of yeasts, dermatophytes and non-dermatophytes in superficial skin infections in Assiut, Egypt Incidence et biodiversite´ des levures, des dermatophytes, et non dermatophytes, agents de mycoses superficielles dans le gouvernorat d’Assiout — ´Egypte A.H. Moubasher, M.A. Abdel-Sater *, Z. Soliman Department of Botany and Microbiology, Faculty of Science, Assiut University Mycological Centre, Assiut University, Assiut, Egypt Received 1st October 2016; received in revised form 28 December 2016; accepted 11 January 2017 Available online 7 February 2017 KEYWORDS Summary Skin infections; Objective. — The aim was to identify the incidence of the causal agents from dermatophytes, Yeasts; non-dermatophytes and yeasts in Assiut Governorate employing, beside the morphological and Dermatophytic; physiological techniques, the genotypic ones. Non-dermatophytic; Patients. — Samples from infected nails, skin and hair were taken from 125 patients. PCR Materials and methods. — Patients who presented with onychomycosis, tinea capitis, tinea corporis, tinea cruris and tinea pedis during the period from February 2012 to October 2015 were clinically examined and diagnosed by dermatologists and were guided to Assiut University Mycological Centre for direct microscopic examination, culturing and identification. Results. — Onychomycosis was the most common infecting (64.8% of the cases) followed by tinea capitis (17.6%). Direct microscopic preparations showed only 45 positive cases, while 96 cases showed positive cultures. Infections were more frequent in females than males. Fifty-one fungal species and 1 variety were obtained. Yeasts were the main agents being cultured from 46.02% of total cases.